CY1106672T1 - Ενωσεις 1-κυκλικου αμινο-αλκυλοκυκλοεξανιου, φαρμακευτικες συνθεσεις αυτων και η χρηση τους ως αντισπασμωδικα - Google Patents
Ενωσεις 1-κυκλικου αμινο-αλκυλοκυκλοεξανιου, φαρμακευτικες συνθεσεις αυτων και η χρηση τους ως αντισπασμωδικαInfo
- Publication number
- CY1106672T1 CY1106672T1 CY20071100831T CY071100831T CY1106672T1 CY 1106672 T1 CY1106672 T1 CY 1106672T1 CY 20071100831 T CY20071100831 T CY 20071100831T CY 071100831 T CY071100831 T CY 071100831T CY 1106672 T1 CY1106672 T1 CY 1106672T1
- Authority
- CY
- Cyprus
- Prior art keywords
- cyclic amino
- compounds
- pharmaceutical compositions
- alkyl
- group
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229940127307 Noncompetitive NMDA Receptor Antagonists Drugs 0.000 abstract 1
- 230000001773 anti-convulsant effect Effects 0.000 abstract 1
- 230000001366 anti-paroxysmal effect Effects 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 230000036461 convulsion Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- -1 optical isomers Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000024587 synaptic transmission, glutamatergic Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Ορισμένα 1-κυκλικά αμινο-αλκυλοκυκλοεξάνια που επιλέγονται από την ομάδα που αποτελείται από εκείνα με τύπο (I) όπου το R* είναι -(CH2)n-(CR6R7)m-NR8R9 όπου το n+m=0, 1, ή 2 όπου τα R1 έως R7 επιλέγονται ανεξάρτητα από την ομάδα που αποτελείται από υδρογόνο και κατώτερο-αλκύλιο (l-6c), με τουλάχιστον τα R1, R4, και R5 να είναι κατώτερο-αλκύλιο, και όπου τα R8 και R9 μαζί παριστάνουν κατώτερο-αλκυλένιο -(CH2)X- όπου το x είναι 2 έως 5, συμπεριλαμβανομένου, και εναντιομερή, οπτικά ισομερή, ένυδρα, και φαρμακευτικώς αποδεκτά άλατα αυτών, είναι συστηματικώς δραστικοί μη-συναγωνιστικοί ανταγωνιστές υποδοχέα NMDA και είναι συνεπώς χρήσιμοι στην απάλυνση καταστάσεων που προκύπτουν από διαταραχές της γλουταματεργικής διαβίβασης. Πιο σημαντικά, αυτές οι ενώσεις εμφανίζουν εξαιρετική αντισπασμωδική και αντι-παροξυσμική δράση την οποία δεν μοιράζονται με τις στενά-σχετιζόμενες μη-κυκλικές αμινο ενώσεις. Φαρμακευτικές συνθέσεις αυτών και μία μέθοδος αντιμετώπισης καταστάσεων που απαλύνονται με τη χρησιμοποίηση αυτών, ιδιαίτερα η απάλυνση σπασμών και παροξυσμών, και μέθοδος για την παρασκευή των δραστικών ενώσεων 1 -κυκλικού αμινο-αλκυλοκυκλοεξανίου που εμπλέκονται και η κατασκευή φαρμάκων από αυτές.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1999/008317 WO2001032640A1 (en) | 1999-11-01 | 1999-11-01 | 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1106672T1 true CY1106672T1 (el) | 2012-05-23 |
Family
ID=8167482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071100831T CY1106672T1 (el) | 1999-11-01 | 2007-06-21 | Ενωσεις 1-κυκλικου αμινο-αλκυλοκυκλοεξανιου, φαρμακευτικες συνθεσεις αυτων και η χρηση τους ως αντισπασμωδικα |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1228052B1 (el) |
| JP (1) | JP4043236B2 (el) |
| KR (1) | KR100548600B1 (el) |
| CN (1) | CN1264827C (el) |
| AT (1) | ATE361284T1 (el) |
| AU (1) | AU782760B2 (el) |
| CA (1) | CA2389325C (el) |
| CY (1) | CY1106672T1 (el) |
| CZ (1) | CZ20021533A3 (el) |
| DE (1) | DE69936004T2 (el) |
| DK (1) | DK1228052T3 (el) |
| EA (1) | EA005684B1 (el) |
| ES (1) | ES2285870T3 (el) |
| HK (1) | HK1049160B (el) |
| HU (1) | HUP0203275A3 (el) |
| IL (2) | IL149401A0 (el) |
| MX (1) | MXPA02004368A (el) |
| NO (1) | NO322359B1 (el) |
| PL (1) | PL199587B1 (el) |
| PT (1) | PT1228052E (el) |
| SI (1) | SI1228052T1 (el) |
| TW (1) | TWI242547B (el) |
| UA (1) | UA72558C2 (el) |
| WO (1) | WO2001032640A1 (el) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| WO2008065141A1 (en) | 2006-11-30 | 2008-06-05 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
| EP2481408A3 (en) | 2007-03-01 | 2013-01-09 | Probiodrug AG | New use of glutaminyl cyclase inhibitors |
| EP2865670B1 (en) | 2007-04-18 | 2017-01-11 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
| US8486940B2 (en) | 2009-09-11 | 2013-07-16 | Probiodrug Ag | Inhibitors |
| JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
| EP2545047B9 (en) | 2010-03-10 | 2015-06-10 | Probiodrug AG | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
| JP6050264B2 (ja) | 2011-03-16 | 2016-12-21 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
| CN104211663B (zh) * | 2014-08-11 | 2017-01-11 | 杭州偶联医药科技有限公司 | 一种(s)-n-甲氧基-甲基-2-(四氢吡咯基)丙酰胺及其制备方法和应用 |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
| RU2714135C1 (ru) * | 2019-11-22 | 2020-02-12 | Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" | Гидрохлорид (1-метилпиперидин-4-ил)-2-пропилпентаноата, обладающий холинолитической и противосудорожной активностью |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3097207A (en) * | 1958-03-06 | 1963-07-09 | Parke Davis & Co | 1-halophenyl and 1-alkoxyphenyl cyclohexylamines |
| CZ293248B6 (cs) * | 1997-06-30 | 2004-03-17 | Merz Pharma Gmbh & Co. Kgaa | 1-Aminocyklohexanový derivát a farmaceutická kompozice na jeho bázi |
-
1999
- 1999-01-11 UA UA2002054475A patent/UA72558C2/uk unknown
- 1999-11-01 KR KR1020027005621A patent/KR100548600B1/ko not_active IP Right Cessation
- 1999-11-01 EP EP99974146A patent/EP1228052B1/en not_active Expired - Lifetime
- 1999-11-01 ES ES99974146T patent/ES2285870T3/es not_active Expired - Lifetime
- 1999-11-01 PL PL354519A patent/PL199587B1/pl not_active IP Right Cessation
- 1999-11-01 WO PCT/EP1999/008317 patent/WO2001032640A1/en active IP Right Grant
- 1999-11-01 SI SI9930972T patent/SI1228052T1/sl unknown
- 1999-11-01 CZ CZ20021533A patent/CZ20021533A3/cs unknown
- 1999-11-01 DK DK99974146T patent/DK1228052T3/da active
- 1999-11-01 AU AU11585/00A patent/AU782760B2/en not_active Ceased
- 1999-11-01 DE DE69936004T patent/DE69936004T2/de not_active Expired - Fee Related
- 1999-11-01 EA EA200200522A patent/EA005684B1/ru not_active IP Right Cessation
- 1999-11-01 CN CNB998169900A patent/CN1264827C/zh not_active Expired - Fee Related
- 1999-11-01 IL IL14940199A patent/IL149401A0/xx active IP Right Grant
- 1999-11-01 MX MXPA02004368A patent/MXPA02004368A/es not_active IP Right Cessation
- 1999-11-01 HU HU0203275A patent/HUP0203275A3/hu unknown
- 1999-11-01 AT AT99974146T patent/ATE361284T1/de not_active IP Right Cessation
- 1999-11-01 JP JP2001534791A patent/JP4043236B2/ja not_active Expired - Fee Related
- 1999-11-01 CA CA002389325A patent/CA2389325C/en not_active Expired - Fee Related
- 1999-11-01 PT PT99974146T patent/PT1228052E/pt unknown
- 1999-11-15 TW TW088119884A patent/TWI242547B/zh not_active IP Right Cessation
-
2002
- 2002-04-29 IL IL149401A patent/IL149401A/en not_active IP Right Cessation
- 2002-04-30 NO NO20022044A patent/NO322359B1/no not_active IP Right Cessation
-
2003
- 2003-02-18 HK HK03101158.3A patent/HK1049160B/zh not_active IP Right Cessation
-
2007
- 2007-06-21 CY CY20071100831T patent/CY1106672T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106672T1 (el) | Ενωσεις 1-κυκλικου αμινο-αλκυλοκυκλοεξανιου, φαρμακευτικες συνθεσεις αυτων και η χρηση τους ως αντισπασμωδικα | |
| NO2005023I2 (no) | Palonosetron HCI | |
| DE69923849D1 (de) | Quinolin-2-on-derivate verwendbar als antikrebsmittel | |
| EP1361220A4 (en) | CYCLIC COMPOUNDS WITH THROMBOPOIETIN RECEPTAGONISM | |
| HUP0400636A2 (hu) | Azetidinszármazékokat tartalmazó gyógyszerkészítmények, új azetidinszármazékok és előállításuk | |
| ES2108425T3 (es) | Analogos de atp sustituidos con n-alquilo-2. | |
| DK1159279T3 (da) | 4-Oxo-4,7-dihydro-thieno[2,3-b]pyridin-5-carboxamider som antivirale midler | |
| RU94030812A (ru) | Производные фосфоноянтарной кислоты, способ их получения и содержащие эти соединения фармацевтические композиции | |
| DK0734383T3 (da) | Cykliske amidderivater som neurokinin-A-antagonister | |
| EA199800794A1 (ru) | Новые производные арилглициламида, способ их получения и фармацевтическая композиция, содержащая эти соединения | |
| ES2111930T3 (es) | Antagonistas del acido amp y procedimientos de tratamiento con la ayuda de estos. | |
| NO973652L (no) | 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreseptor-antagonist | |
| HUP0101701A2 (hu) | Szubsztituált béta-alaninok és ezeket tartalmazó gyógyszerkészítmények | |
| DE69132689D1 (de) | Biologisch aktive amine | |
| CY1105550T1 (el) | Μεμνο-πεπτιδια, μια διαδικασια για την παρασκευη και τη χρηση τους | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| NO973341L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse | |
| MY143862A (en) | Piperidine-substituted indoles-or heteroderivatives thereof | |
| BG105521A (en) | Benzisoxazoles and phenons as alpha2-antagonists | |
| DE60208347D1 (de) | Verwendung von "xylyloxy alkyl amines" für die Behandlung von Tinnitus | |
| DK0573360T3 (da) | Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister | |
| ECSP951434A (es) | Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos (ii) | |
| FI933652A (fi) | Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler |